Editas Medicine Inc (EDIT)
1.34
-0.11
(-7.59%)
USD |
NASDAQ |
Jan 08, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine SG&A Expense (Quarterly): 18.09M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 61.60M |
| Johnson & Johnson | 5.278B |
| Pfizer Inc | 3.244B |
| Revvity Inc | 239.48M |
| Kodiak Sciences Inc | 14.75M |